| John O Simmons, MD | |
|
1114 W 7th St, Columbia, TN 38401-1810 | |
| (931) 388-9706 | |
| (931) 490-1062 |
| Full Name | John O Simmons |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 1114 W 7th St, Columbia, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245208602 | NPI | - | NPPES |
| 3044041 | Medicaid | TN | |
| 3710089 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 019639 (Tennessee) | Primary |
| Entity Name | Maury Regional Medical Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205886264 PECOS PAC ID: 7911810742 Enrollment ID: O20040227000252 |
News Archive
The ever growing complexity of various simulation tasks not only require a continuous increase of computing power but also the capability of managing large amounts of data.
BiondVax announced today that priming with universal flu vaccine before boosting with a conventional bird flu H5N1 vaccine (containing a single strain from Clade 1) resulted in mice exhibiting a significantly higher level of immunity to the strain contained in the conventional bird flu vaccine and in addition, broadened immunity to other H5N1 flu strains (from Clade 2).
Laramie, Wyoming, is a long way from Waycross, Georgia. Dr. Joel Higgins has mixed feelings about departing the Peach State. Born in Augusta, he practiced in Waycross as an ob/gyn from 2001 until last December. ... But a deteriorating financial situation drove him to move to Wyoming, he says. ... Roughly 70 percent of Higgins' Waycross patients were on Medicaid, the government insurance program for the poor and disabled.
Regulus Therapeutics Inc. today announced the publication of new results in the journal Nature Biotechnology by Regulus scientists and collaborators. The new study demonstrated that systemic treatment of a microRNA therapeutic targeting microRNA-10b in tumor-bearing mice inhibits breast cancer metastasis. Cancer-related metastasis is a major cause of mortality and current cancer treatments have limited utility suppressing the metastatic spread of cancer cells. microRNA therapeutics targeting miR-10b represent a promising approach for the discovery and development of a novel anti-metastatic agent.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John O Simmons, MD 854 W James Campbell Blvd, Suite 303, Columbia, TN 38401-4659 Ph: (931) 388-9706 | John O Simmons, MD 1114 W 7th St, Columbia, TN 38401-1810 Ph: (931) 388-9706 |
News Archive
The ever growing complexity of various simulation tasks not only require a continuous increase of computing power but also the capability of managing large amounts of data.
BiondVax announced today that priming with universal flu vaccine before boosting with a conventional bird flu H5N1 vaccine (containing a single strain from Clade 1) resulted in mice exhibiting a significantly higher level of immunity to the strain contained in the conventional bird flu vaccine and in addition, broadened immunity to other H5N1 flu strains (from Clade 2).
Laramie, Wyoming, is a long way from Waycross, Georgia. Dr. Joel Higgins has mixed feelings about departing the Peach State. Born in Augusta, he practiced in Waycross as an ob/gyn from 2001 until last December. ... But a deteriorating financial situation drove him to move to Wyoming, he says. ... Roughly 70 percent of Higgins' Waycross patients were on Medicaid, the government insurance program for the poor and disabled.
Regulus Therapeutics Inc. today announced the publication of new results in the journal Nature Biotechnology by Regulus scientists and collaborators. The new study demonstrated that systemic treatment of a microRNA therapeutic targeting microRNA-10b in tumor-bearing mice inhibits breast cancer metastasis. Cancer-related metastasis is a major cause of mortality and current cancer treatments have limited utility suppressing the metastatic spread of cancer cells. microRNA therapeutics targeting miR-10b represent a promising approach for the discovery and development of a novel anti-metastatic agent.
› Verified 1 days ago
Jessica Joseph-alexis, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 1220 Trotwood Ave Ste 401, Columbia, TN 38401 Phone: 931-388-8622 | |
Dr. Hany Nimr Rezk, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 854 W James Campbell Blvd, Ste. 101a, Columbia, TN 38401 Phone: 931-388-3209 Fax: 931-388-0105 | |
Anthony Donald Haase Iii, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1224 Trotwood Ave, Columbia, TN 38401 Phone: 931-380-4072 Fax: 931-490-7043 | |
Christopher R Edwards, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1224 Trotwood Ave, Columbia, TN 38401 Phone: 931-381-1111 | |
Dr. Cheryl Buttram Clayton, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 854 W James Campbell Blvd, Ste. 101a, Columbia, TN 38401 Phone: 931-388-3209 Fax: 931-388-0105 | |
John Spencer Jensen, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1222 Trotwood Ave, Suite 503, Columbia, TN 38401 Phone: 931-490-7775 Fax: 931-490-7797 | |
Dominic J Papa, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1224 Trotwood Ave, Columbia, TN 38401 Phone: 931-380-4032 Fax: 931-490-7043 |